DUBLIN, Feb. 20, 2024 /PRNewswire/ -- Jazz
Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company
management will participate in the following investor
conferences:
TD Cowen's 44th Annual Health Care Conference on Monday, March 4, 2024
- Fireside chat at 7:30 a.m. PT /
10:30 a.m. ET / 3:30 p.m. GMT
Leerink Partners Global Biopharma Conference 2024 on
Monday, March 11, 2024
- Fireside chat at 11:00 a.m. PT /
2:00 p.m. ET / 7:00 p.m. GMT
Audio webcasts of the presentations will be available via the
Investors section of the Jazz Pharmaceuticals website at
https://investor.jazzpharma.com/investors/events-presentations. A
replay of the webcasts will be archived on the website for 30
days.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals
plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose
purpose is to innovate to transform the lives of patients and their
families. We are dedicated to developing life-changing medicines
for people with serious diseases – often with limited or no
therapeutic options. We have a diverse portfolio of marketed
medicines and novel product candidates, from early- to late-stage
development, in neuroscience and oncology. Within these therapeutic
areas, we are identifying new options for patients by actively
exploring small molecules and biologics, and through innovative
delivery technologies and cannabinoid science. Jazz is
headquartered in Dublin, Ireland and has employees around
the globe, serving patients in nearly 75 countries. Please
visit
www.jazzpharmaceuticals.com for more information.
Contacts:
Investors:
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Ireland +353 1 634 3211
U.S. +1 650 496 2717
Media:
Kristin
Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 637 2141
U.S. +1 215 867 4948
Logo -
https://mma.prnewswire.com/media/272253/Jazz_Pharmaceuticals_New_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/jazz-pharmaceuticals-to-participate-in-upcoming-march-investor-conferences-302066570.html